Objective: To investigate the effect of the tumour necrosis factor (TNF) blocking agent
infliximab in patients with treatment-resistant inflammatory myopathies. Methods: A total of 13 …

Selective immunoglobulin A deficiency (IgAD) is the most common primary immunodeficiency
in Caucasians. It has previously been suggested to be associated with a variety of …

Introduction Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. Cardiovascular
disease (CVD) is common and a major cause of mortality. Studies on cardiovascular …

Introduction Cardiovascular disease (CVD) is a major cause of premature mortality among
Systemic lupus erythematosus (SLE) patients. Many studies have measured and evaluated …

Background Systemic lupus erythematosus (SLE), is a heterogeneous disease which
predominantly affects young females (90%). SLE is associated with a shorter life expectancy than …

Objective Smoking can induce autoantibodies in persons who are genetically predisposed
to rheumatoid arthritis. We investigated the association between smoking and …

Objective To investigate whether the risk allele for systemic lupus erythematosus (SLE) in the
signal transducer and activator of transcription factor 4 (STAT4) gene, defined by the single …

Objective The heterogeneity of systemic lupus erythematosus (SLE) constitutes clinical and
therapeutical challenges. We therefore studied whether unrecognized disease subgroups …

Background and objectives Vascular disease is common in systemic lupus erythematosus (SLE)
and patients with antiphospholipid antibodies (aPL) are at high risk to develop arterial …

Objective. An often-neglected subset of patients with systemic lupus erythematosus (SLE) is
those with secondary Sjögren syndrome (SLE-sSS). Further, primary SS overlaps and can …